TY - UNPB
T1 - Drug repurposing prediction for COVID-19 using probabilistic networks and crowdsourced curation
AU - Skelton, David J.
AU - Alsobhe, Aoesha
AU - Anastasi, Elisa
AU - Atallah, Christian
AU - Bird, Jasmine E.
AU - Brown, Bradley
AU - Didon, Dwayne
AU - Gater, Phoenix
AU - James, Katherine
AU - Jr, David D. Lennon
AU - McLaughlin, James
AU - Moreland, Pollyanna E. J.
AU - Pocock, Matthew
AU - Whitaker, Caroline J.
AU - Wipat, Anil
N1 - 30 pages, 5 figures, 2 tables + 1 additional table in supporting material
PY - 2020/5/22
Y1 - 2020/5/22
N2 - Severe acute respiratory syndrome coronavirus two (SARS-CoV-2), the virus responsible for the coronavirus disease 2019 (COVID-19) pandemic, represents an unprecedented global health challenge. Consequently, a large amount of research into the disease pathogenesis and potential treatments has been carried out in a short time frame. However, developing novel drugs is a costly and lengthy process, and is unlikely to deliver a timely treatment for the pandemic. Drug repurposing, by contrast, provides an attractive alternative, as existing drugs have already undergone many of the regulatory requirements. In this work we used a combination of network algorithms and human curation to search integrated knowledge graphs, identifying drug repurposing opportunities for COVID-19. We demonstrate the value of this approach, reporting on eight potential repurposing opportunities identified, and discuss how this approach could be incorporated into future studies.
AB - Severe acute respiratory syndrome coronavirus two (SARS-CoV-2), the virus responsible for the coronavirus disease 2019 (COVID-19) pandemic, represents an unprecedented global health challenge. Consequently, a large amount of research into the disease pathogenesis and potential treatments has been carried out in a short time frame. However, developing novel drugs is a costly and lengthy process, and is unlikely to deliver a timely treatment for the pandemic. Drug repurposing, by contrast, provides an attractive alternative, as existing drugs have already undergone many of the regulatory requirements. In this work we used a combination of network algorithms and human curation to search integrated knowledge graphs, identifying drug repurposing opportunities for COVID-19. We demonstrate the value of this approach, reporting on eight potential repurposing opportunities identified, and discuss how this approach could be incorporated into future studies.
U2 - 10.48550/arXiv.2005.11088
DO - 10.48550/arXiv.2005.11088
M3 - Preprint
BT - Drug repurposing prediction for COVID-19 using probabilistic networks and crowdsourced curation
ER -